Skip to main content
Omar Aljitawi, MD, Oncology, Rochester, NY

OmarSalahAljitawiMD

Oncology Rochester, NY

Hematologic Oncology

Assistant Professor, Internal Medicine, University Kansas School of Medicine

Dr. Aljitawi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Aljitawi's full profile

Already have an account?

  • Office

    601 Elmwood Ave
    Rochester, NY 14642
    Phone+1 585-275-5823
    Fax+1 913-588-3996

Education & Training

  • University of Kansas School of Medicine
    University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2004 - 2007
  • East Tennessee State University/Quillen College of Medicine
    East Tennessee State University/Quillen College of MedicineResidency, Internal Medicine, 2001 - 2004
  • University of Jordan Faculty of Medicine
    University of Jordan Faculty of MedicineClass of 1999

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2016 - 2026
  • CA State Medical License
    CA State Medical License 2007 - 2025
  • KS State Medical License
    KS State Medical License 2004 - 2016

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant Cyclophosphamide
    Omar S. Aljitawi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Wilmot Discovery Improves Use of Umbilical Cord Blood as Cancer Therapy
    Wilmot Discovery Improves Use of Umbilical Cord Blood as Cancer TherapyJanuary 4th, 2017